Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but there's another option.

When you buy through links on our articles, Future and its syndication partners may earn a commission. A new blood-based test for colorectal cancer is designed to screen for cancer-related DNA ...

The newest version of Cologuard, an at-home colon cancer screening test, results in fewer false positives that can lead to unnecessary follow-up procedures. Cologuard Plus also gives people more time ...

Cancer usually grows quietly for years before it causes pain, bleeding or weight loss. By the time symptoms appear, disease ...

Madison-based Exact Sciences will be acquired by Abbott Laboratory for roughly $23 billion in a deal that was announced Nov.

More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...

The fecal immunochemical test (FIT) and multitarget stool DNA (mt-sDNA) test are two of the most commonly used noninvasive screening tests for colorectal cancer. A new study analyzing data from a ...

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

The Food and Drug Administration approved a blood test that can detect colorectal cancer, CBS News reported. It’s called Shield and was developed by Guardant Health Inc. The test was approved by the ...

The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...